help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SANDOVAL, J.
Right arrow Articles by BAUTISTA, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SANDOVAL, J.
Right arrow Articles by BAUTISTA, E.

Am. J. Respir. Crit. Care Med., Volume 164, Number 9, November 2001, 1682-1687

Nocturnal Oxygen Therapy in Patients with the Eisenmenger Syndrome

JULIO SANDOVAL, JANET S. AGUIRRE, TOMÁS PULIDO, MARIA LUISA MARTINEZ-GUERRA, EFRÉN SANTOS, PEDRO ALVARADO, MARTIN ROSAS, and EDGAR BAUTISTA

Cardiopulmonary Department, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico

This prospective and controlled pilot study evaluates the long-term effects of nocturnal oxygen therapy (NOT) on exercise endurance, hematology variables, quality of life, and survival of 23 adult patients (mean age, 32 ± 6 yr) with post-tricuspid congenital heart defects (ventricular septal defect = 10; patent ductus arteriosus = 13) and Eisenmenger Syndrome. All had pulmonary hypertension (mean pulmonary artery pressure = 88 ± 20 mm Hg), severe hypoxemia (PaO2 = 44 ± 5 mm Hg), and secondary erythrocytosis (hematocrit = 61.5 ± 7%). Exercise endurance (6-min walk test = 380 ± 88 m) was limited. In a random fashion, NOT was given to one group of patients (n = 12) but withheld from a comparable control group (n = 11). At 2 yr of close follow-up, two patients in the group of control patients, and three in the treatment group died. Mean survival estimates were similar in both groups (20.7 versus 20.8 mo; chi-square log-rank, 0.08; p = NS). Likewise, none of the hematology, exercise capacity, and quality of life variables examined showed statistically significant changes that were dependent on treatment regimen. We conclude that NOT does not modify the natural history of patients with advanced Eisenmenger Syndrome.




This article has been cited by other articles:


Home page
HeartHome page
National Pulmonary Hypertension Centres of the UK
Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland
Heart, March 1, 2008; 94(Suppl_1): i1 - i41.
[Full Text] [PDF]


Home page
ThoraxHome page
National Pulmonary Hypertension Centres of the UK
Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland
Thorax, March 1, 2008; 63(Suppl_2): ii1 - ii41.
[Full Text] [PDF]


Home page
CirculationHome page
G.-P. Diller and M. A. Gatzoulis
Pulmonary Vascular Disease in Adults With Congenital Heart Disease
Circulation, February 27, 2007; 115(8): 1039 - 1050.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
G.-P. Diller, K. Dimopoulos, C. S. Broberg, M. G. Kaya, U. S. Naghotra, A. Uebing, C. Harries, O. Goktekin, J. S. R. Gibbs, and M. A. Gatzoulis
Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: a combined retrospective and case-control study
Eur. Heart J., July 2, 2006; 27(14): 1737 - 1742.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
L. J. Rubin and D. B. Badesch
Evaluation and Management of the Patient with Pulmonary Arterial Hypertension
Ann Intern Med, August 16, 2005; 143(4): 282 - 292.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P. Moons, K. Van Deyk, K. Marquet, E. Raes, L. De Bleser, W. Budts, and S. De Geest
Individual quality of life in adults with congenital heart disease: a paradigm shift
Eur. Heart J., February 1, 2005; 26(3): 298 - 307.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
I M Balfour-Lynn, R A Primhak, and B N J Shaw
Home oxygen for children: who, how and when?
Thorax, January 1, 2005; 60(1): 76 - 81.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Task Force members, N. Galie, A. Torbicki, R. Barst, P. Dartevelle, S. Haworth, T. Higenbottam, H. Olschewski, A. Peacock, G. Pietra, et al.
Guidelines on diagnosis and treatment of pulmonary arterial hypertension: The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology
Eur. Heart J., December 2, 2004; 25(24): 2243 - 2278.
[Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
P. Moons, K. Van Deyk, W. Budts, and S. De Geest
Caliber of Quality-of-Life Assessments in Congenital Heart Disease: A Plea for More Conceptual and Methodological Rigor
Arch Pediatr Adolesc Med, November 1, 2004; 158(11): 1062 - 1069.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. M. Hoeper, R. J. Oudiz, A. Peacock, V. F. Tapson, S. G. Haworth, A. E. Frost, and A. Torbicki
End points and clinical trial designs in pulmonary arterial hypertension: Clinical and regulatory perspectives
J. Am. Coll. Cardiol., June 16, 2004; 43(12_Suppl_S): 48S - 55S.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
N. Galie, W. Seeger, R. Naeije, G. Simonneau, and L. J. Rubin
Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension
J. Am. Coll. Cardiol., June 16, 2004; 43(12_Suppl_S): 81S - 88S.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A. Widlitz and R.J. Barst
Pulmonary arterial hypertension in children
Eur. Respir. J., January 1, 2003; 21(1): 155 - 176.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. TOBIN
Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2001
Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 642 - 662.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2001 American Thoracic Society
  Solid Organ Transplant for the Intensivist 2008